BioLineRx Ltd. Interest Expense
BioLineRx Ltd. (BLRX) reported Interest Expense of $1.25 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement
ifrs-full:InterestExpense · last filed 2026-03-23
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | $1.25M 20-F · filed 2026-03-23 |
| 2024-12-31 | $9.07M 20-F · filed 2026-03-23 |
| 2023-12-31 | $2.14M 20-F · filed 2026-03-23 |
| 2022-12-31 | $1.79M 20-F · filed 2025-03-31 |
| 2021-12-31 | $984.00K 20-F · filed 2024-03-26 |
| 2020-12-31 | $1.47M 20-F · filed 2023-03-22 |